Similarly, Bhola et al. [32] investigated how the TGF-β signaling pathway increased the relapse of breast carcinoma through IL-8-induced expansion of cancer stem cells and stimulation of the development of chemoresistant cancer stem cells to paclitaxel. Here, TGFB1 is linked to breast carcinoma.